Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

MiCardia Corporation

Request full access

Medical equipment manufacturing

Irvine, United StatesFounded 2004Health Tech & Medtech

About MiCardia Corporation

MiCardia Corporation, established in 2004 and based in Irvine, California, is a privately-held medical device company focused on treatments for structural heart disease. The company operates within the surgical devices industry, specifically developing solutions for mitral and tricuspid valve disorders.

The core of MiCardia's business revolves around its proprietary Dynaplasty technology, which is designed to allow for the adjustment of cardiac implants both during and after a surgical procedure. This technology is embodied in its enCor Mitral Valve Repair System, which received CE Mark approval in 2011, permitting its commercialization in the European Union. The system includes the enCorSQ, an annuloplasty device for treating mitral regurgitation (MR), a condition where the heart's mitral valve fails to close properly. A key feature of the enCorSQ is its ability to be adjusted post-implantation in a minimally invasive manner, addressing recurrent regurgitation that can happen as a patient's underlying cardiovascular disease progresses, thereby potentially avoiding repeat open-heart surgeries.

MiCardia's business model centers on the development and sale of these specialized medical devices to healthcare institutions. The company has engaged in multiple funding rounds to support its operations and product commercialization, raising a total of over $33 million. A significant milestone occurred in 2012 when MiCardia spun off its transcatheter technology business into a new entity, ValCar Inc., backed by an $8 million investment to further develop catheter-based, non-surgical implantation methods. The company continues to hold patents for its adjustable implant technologies.

Source: Dealroom company data

MiCardia Corporation in the Irvine ecosystem

Live from Dealroom

The MiCardia Corporation office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • DNX Ventures
  • MedFocus Fund
  • BioStar Capital
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Irvine HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about MiCardia Corporation on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See MiCardia Corporation on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.